Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Walter

Showing results (261-270 of 334) with videos related to

Pageof 34
Sort By:
The International Journal of Biological Markers|May 17, 2011
Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up studyDelphine Vezzosi, Thomas Walter, Agnès Laplanche, et al.
Neuroendocrinology|March 9, 2018
Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine NeoplasmsAnna Pellat, Chantal Dreyer, Camille Couffignal, et al.
Nature Communications|January 12, 2025
Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancerNicolas Captier, Marvin Lerousseau, Fanny Orlhac, et al.
International Journal of Cancer|January 6, 2021
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1)Eric Assenat, Laurent Mineur, Caroline Mollevi, et al.
Nature Methods|March 3, 2010
Visualization of image data from cells to organismsThomas Walter, David W Shattuck, Richard Baldock, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 4, 2022
Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)Nicolas Benech, Sylvie Bonvalot, Armelle Dufresne, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN NetworkAurelien Fosse, Julien Hadoux, Paul Girot, et al.
Endoscopy|June 1, 2022
Diagnostic endoscopic submucosal dissection for colorectal lesions with suspected deep invasionAdrien Patenotte, Clara Yzet, Timothée Wallenhorst, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2026
Self-supervised learning to predict intrahepatic cholangiocarcinoma transcriptomic classes on routine histologyAurélie Beaufrère, Tristan Lazard, Rémy Nicolle, et al.
Annals of Nuclear Medicine|March 26, 2017
Survival and prognostic factors after adjuvant <sup>131</sup>iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 yearsJonathan Olesinski, François Mithieux, Olivier Guillaud, et al.
Pageof 34

Showing results (261-270 of 334) with videos related to

Sort By:
Pageof 34
The International Journal of Biological Markers|May 17, 2011
Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up studyDelphine Vezzosi, Thomas Walter, Agnès Laplanche, et al.
Neuroendocrinology|March 9, 2018
Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine NeoplasmsAnna Pellat, Chantal Dreyer, Camille Couffignal, et al.
Nature Communications|January 12, 2025
Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancerNicolas Captier, Marvin Lerousseau, Fanny Orlhac, et al.
International Journal of Cancer|January 6, 2021
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1)Eric Assenat, Laurent Mineur, Caroline Mollevi, et al.
Nature Methods|March 3, 2010
Visualization of image data from cells to organismsThomas Walter, David W Shattuck, Richard Baldock, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 4, 2022
Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)Nicolas Benech, Sylvie Bonvalot, Armelle Dufresne, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN NetworkAurelien Fosse, Julien Hadoux, Paul Girot, et al.
Endoscopy|June 1, 2022
Diagnostic endoscopic submucosal dissection for colorectal lesions with suspected deep invasionAdrien Patenotte, Clara Yzet, Timothée Wallenhorst, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2026
Self-supervised learning to predict intrahepatic cholangiocarcinoma transcriptomic classes on routine histologyAurélie Beaufrère, Tristan Lazard, Rémy Nicolle, et al.
Annals of Nuclear Medicine|March 26, 2017
Survival and prognostic factors after adjuvant <sup>131</sup>iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 yearsJonathan Olesinski, François Mithieux, Olivier Guillaud, et al.
Pageof 34